2018 - Fellow of the Indian National Academy of Engineering (INAE)
2014 - Fellow of the American Association for the Advancement of Science (AAAS)
2013 - Fellow, National Academy of Inventors
Member of the Association of American Physicians
Stephen B. Liggett spends much of his time researching Internal medicine, Endocrinology, Receptor, Heart failure and Agonist. His Internal medicine research includes elements of Denatonium and Valine. His research in Endocrinology intersects with topics in Cardiac function curve and Phospholamban.
Adrenergic receptor is the focus of his Receptor research. His Heart failure research includes themes of Muscle hypertrophy, Heart disease and Beta adrenergic receptor kinase. His studies in Agonist integrate themes in fields like Beta-1 adrenergic receptor, Molecular biology and Methacholine.
His primary scientific interests are in Receptor, Internal medicine, Endocrinology, Agonist and Adrenergic receptor. The study incorporates disciplines such as Molecular biology and Signal transduction, Cell biology in addition to Receptor. His Internal medicine study frequently links to other fields, such as Cardiology.
His research integrates issues of Adrenergic and Protein kinase A in his study of Endocrinology. His research in Agonist intersects with topics in Tachyphylaxis and Downregulation and upregulation. His Adrenergic receptor research includes elements of Disease and Pharmacology.
Stephen B. Liggett mainly focuses on Receptor, Cell biology, Internal medicine, Endocrinology and Agonist. The study incorporates disciplines such as Tachyphylaxis, Pharmacology, Cell and Downregulation and upregulation in addition to Receptor. His work on G protein, Kinase, Phosphorylation and Myocyte as part of his general Cell biology study is frequently connected to Tauopathy, thereby bridging the divide between different branches of science.
His study in Internal medicine is interdisciplinary in nature, drawing from both Pharmacogenetics and Cardiology. His Endocrinology research is multidisciplinary, incorporating perspectives in Haplotype, Bronchodilator, Function and Adrenergic receptor. His work in Agonist covers topics such as Internalization which are related to areas like TAS2R14, Desensitization, Gene knockdown and CREB.
Stephen B. Liggett mainly investigates Internal medicine, Endocrinology, Receptor, Myocyte and Stimulation. His study brings together the fields of Cardiology and Internal medicine. His Endocrinology study combines topics in areas such as Adrenergic receptor, Pharmacogenetics, Intracellular, Bronchodilator and Haplotype.
His Receptor study integrates concerns from other disciplines, such as Tachyphylaxis, Cell, Taste and Cell biology. His Tachyphylaxis research incorporates elements of Agonist and Homologous desensitization. His Myocyte research is multidisciplinary, relying on both Inflammation and Rho-associated protein kinase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.
Connie M. Drysdale;Dennis W. McGraw;Catharine B. Stack;J. Claiborne Stephens.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.
Stuart A. Green;Jamal Turki;Michael Innis;Stephen B. Liggett.
Transgenic Gαq overexpression induces cardiac contractile failure in mice
Drew D. D’Angelo;Yoshihito Sakata;John N. Lorenz;Gregory P. Boivin.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Mutations in the Gene Encoding for the β2-adrenergic Receptor in Normal and Asthmatic Subjects
Ellen Reihsaus;Michael Innis;Neil MacIntyre;Stephen B. Liggett.
American Journal of Respiratory Cell and Molecular Biology (1993)
A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor
D A Mason;J D Moore;S A Green;S B Liggett.
Journal of Biological Chemistry (1999)
The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma
Elliot Israel;Jeffrey M. Drazen;Stephen B. Liggett;Homer A. Boushey.
American Journal of Respiratory and Critical Care Medicine (2000)
PKC-alpha regulates cardiac contractility and propensity toward heart failure.
Julian C Braz;Kimberly Gregory;Anand Pathak;Wen Zhao.
Nature Medicine (2004)
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Elliot Israel;Vernon M. Chinchilli;Jean G. Ford;Homer A. Boushey.
The Lancet (2004)
A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor.
S A Green;G Cole;M Jacinto;M Innis.
Journal of Biological Chemistry (1993)
Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
John W. Adams;Yoshihito Sakata;Michael G. Davis;Valerie P. Sah.
Proceedings of the National Academy of Sciences of the United States of America (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: